Michael Zeschnigk

5.2k total citations · 1 hit paper
72 papers, 3.3k citations indexed

About

Michael Zeschnigk is a scholar working on Molecular Biology, Ophthalmology and Genetics. According to data from OpenAlex, Michael Zeschnigk has authored 72 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 35 papers in Ophthalmology and 16 papers in Genetics. Recurrent topics in Michael Zeschnigk's work include Ocular Oncology and Treatments (35 papers), Epigenetics and DNA Methylation (23 papers) and Genetic Syndromes and Imprinting (8 papers). Michael Zeschnigk is often cited by papers focused on Ocular Oncology and Treatments (35 papers), Epigenetics and DNA Methylation (23 papers) and Genetic Syndromes and Imprinting (8 papers). Michael Zeschnigk collaborates with scholars based in Germany, United States and Japan. Michael Zeschnigk's co-authors include Dietmar Lohmann, Bernhard Horsthemke, Anna Starzinski‐Powitz, Norbert Bornfeld, Karin Buiting, Walter Doerfler, Andrey Irintchev, A. Wernig, Christina Lich and Claudia H.D. Metz and has published in prestigious journals such as Nucleic Acids Research, Nature Genetics and Bioinformatics.

In The Last Decade

Michael Zeschnigk

71 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3

2013 369 citations Marcel Martin, Petra Temming et al. Nature Genetics profile →

Peers

Countries citing papers authored by Michael Zeschnigk

Since Specialization

Citations

This map shows the geographic impact of Michael Zeschnigk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Zeschnigk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Zeschnigk more than expected).

Fields of papers citing papers by Michael Zeschnigk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Zeschnigk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Zeschnigk. The network helps show where Michael Zeschnigk may publish in the future.

Co-authorship network of co-authors of Michael Zeschnigk

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Zeschnigk. A scholar is included among the top collaborators of Michael Zeschnigk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Zeschnigk. Michael Zeschnigk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Presence of tumor DNA in aqueous humor is correlated with high risk uveal melanoma 2025 ·Scientific Reports ·(unknown), M. J. Lever, (unknown), (unknown), Miltiadis Fiorentzis, Nikolaos E. Bechrakis, Dietmar Lohmann, Michael Zeschnigk, (unknown)	0
2	Mass Spectrometry-Based Profiling of Histone Post-Translational Modifications in Uveal Melanoma Tissues, Human Melanocytes, and Uveal Melanoma Cell Lines – A Pilot Study 2024 ·Investigative Ophthalmology & Visual Science ·Martina C. Herwig‐Carl, Amit Sharma, Verena Tischler, (unknown), Karin U. Loeffler, Frank G. Holz, Michael Zeschnigk, Solange Landreville, Claudia Auw‐Haedrich, Roberta Noberini, Tiziana Bonaldi	3
3	No evidence for intervention-associated DNA methylation changes in monocytes of patients with posttraumatic stress disorder 2022 ·Scientific Reports ·Elisabeth Hummel, Magdeldin Elgizouli, Maurizio Sicorello, Elsa Leitão, Jasmin Beygo, Christopher Schröder, Michael Zeschnigk, (unknown), Stephan Herpertz, Dirk Moser, Henrik Kessler, Bernhard Horsthemke, Robert Kumsta	7
4	Secondary Somatic Mutations in G-Protein-Related Pathways and Mutation Signatures in Uveal Melanoma 2019 ·Cancers ·Francesca Piaggio, (unknown), Cinzia Bernardi, Michela Croce, Roberto Puzone, Silvia Viaggi, (unknown), Annalisa Barla, Domenico Coviello, Martine J. Jager, Pieter A. van der Velden, Michael Zeschnigk, Davide Cangelosi, Alessandra Eva, Ulrich Pfeffer, Adriana Amaro	22
5	eIF1A residues implicated in cancer stabilize translation preinitiation complexes and favor suboptimal initiation sites in yeast 2017 ·eLife ·Pilar Martín-Marcos, Fujun Zhou, (unknown), Fan Zhang, Jinsheng Dong, Jagpreet S. Nanda, (unknown), Neelam Dabas Sen, Mercedes Tamame, Michael Zeschnigk, Jon R. Lorsch, Alan G. Hinnebusch	78
6	Methylation analysis of SST and SSTR4 promoters in the neocortex of Alzheimer's disease patients 2014 ·Neuroscience Letters ·Christian Großer, (unknown), Bernhard Horsthemke, Michael Zeschnigk, Johannes van de Nes	8
7	A new face of Borjeson–Forssman–Lehmann syndrome? De novo mutations in PHF6 in seven females with a distinct phenotype 2013 ·Journal of Medical Genetics ·Christiane Zweier, Cornelia Kraus, Louise Brueton, Trevor Cole, Franziska Degenhardt, Hartmut Engels, Gabriele Gillessen‐Kaesbach, Luitgard Graul‐Neumann, Denise Horn, Juliane Hoyer, Walter Just, Anita Rauch, André Reis, Bernd Wollnik, Michael Zeschnigk, Hermann‐Josef Lüdecke, Dagmar Wieczorek	32
8	Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3 breakdown → 2013 ·Nature Genetics ·Marcel Martin, (unknown), Petra Temming, Sven Rahmann, Claudia H.D. Metz, Norbert Bornfeld, Johannes van de Nes, Ludger Klein‐Hitpaß, Alan G. Hinnebusch, Bernhard Horsthemke, Dietmar Lohmann, Michael Zeschnigk	369
9	Lack of SF3B1 R625 mutations in cutaneous melanoma 2013 ·Diagnostic Pathology ·Bastian Schilling, Nicola Bielefeld, Antje Sucker, Uwe Hillen, Lisa Zimmer, Dirk Schadendorf, Michael Zeschnigk, Klaus Griewank	15
10	Quality Assessment Of Multiplex Ligation-dependent Probe Amplification (mlpa) In Uveal Melanoma By Comparison With Array Comparative Genomic Hybridization (acgh) And Microsatellite Analysis (msa) 2012 ·Investigative Ophthalmology & Visual Science ·Sarah E. Coupland, Helen Kalirai, (unknown), Una Maye, Michael Zeschnigk, Bertil Damato	1
11	Molecular pathology of uveal melanoma 2012 ·Eye ·Sarah E. Coupland, Sarah L. Lake, Michael Zeschnigk, Bertil Damato	121
12	Expression of MCSP and PRAME in conjunctival melanoma 2010 ·British Journal of Ophthalmology ·Henrike Westekemper, (unknown), Daniela Süßkind, (unknown), (unknown), Daniel Meller, Michael Zeschnigk, K.–P. Steuhl, Norbert Bornfeld, K. W. Schmid, Florian Grabellus	25
13	Novel Cell Lines Derived by Long-Term Culture of Primary Uveal Melanomas 2009 ·Ophthalmologica ·(unknown), Michael Zeschnigk, Norbert Bornfeld, Gerasimos Anastassiou	20
14	Establishment and characterization of two uveal melanoma cell lines derived from tumors with loss of one chromosome 3 2006 ·Experimental Eye Research ·(unknown), Michael Zeschnigk, Gabriele Prescher, Dietmar Lohmann, Gerasimos Anastassiou	21
15	Spectrum of gross deletions and insertions in theRB1 gene in patients with retinoblastoma and association with phenotypic expression 2005 ·Human Mutation ·(unknown), (unknown), Andreas Schüler, Michael Zeschnigk, Brenda L. Gallie, Dietmar Lohmann	57
16	A novel real-time PCR assay for quantitative analysis of methylated alleles (QAMA): analysis of the retinoblastoma locus 2004 ·Nucleic Acids Research ·Michael Zeschnigk	104
17	Combining DNA expression with positional information to detect functional silencing of chromosomal regions 2003 ·Bioinformatics ·Johannes Hüsing, Michael Zeschnigk, Tanja Boes, Karl‐Heinz Jöckel	11
18	Prognostisch relevante Marker bei malignem Melanom der Uvea 2002 ·Der Ophthalmologe ·Gerasimos Anastassiou, Frank Tschentscher, Michael Zeschnigk	7
19	Identification of chromosomes 3, 6, and 8 aberrations in uveal melanoma by microsatellite analysis in comparison to comparative genomic hybridization 2000 ·Cancer Genetics and Cytogenetics ·Frank Tschentscher, Gabriele Prescher, Michael Zeschnigk, Bernhard Horsthemke, Dietmar Lohmann	84
20	Molecular-Cloning, Characterization, and Mapping of a Full-Length cDNA Encoding Human UDP-Galactose 4′-Epimerase 1995 ·Biochemical and Molecular Medicine ·(unknown), Tim Gallaher, Michael Zeschnigk, Anna Starzinski‐Powitz, Klaus G. Petry, Ian S. Haworth, Juergen Reichardt	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact